Aytu BioPharma, Inc. revenue breakdown overview

Aytu BioPharma, Inc. revenue for the last year amounted to 81.00 M USD, the most of which — 65.18 M USD — came from its highest performing source at the moment, Rx, the year earlier bringing 73.80 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Aytu BioPharma, Inc. 80.91 M USD, and the year before that — 106.92 M USD.